Expanded Access Program of Ponatinib

Clinical trial NCT01592136 · APPROVED_FOR_MARKETING

Trial details

NCT number: NCT01592136
Sponsor: Ariad Pharmaceuticals
Status: APPROVED_FOR_MARKETING
Study type: EXPANDED_ACCESS

Chronic Myeloid Leukemia (CML)Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL)

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.